Pearson's Pharmacy, Inc. v. Express Scripts, Inc.

378 F. App'x 934
CourtCourt of Appeals for the Eleventh Circuit
DecidedMay 10, 2010
Docket09-15830
StatusUnpublished

This text of 378 F. App'x 934 (Pearson's Pharmacy, Inc. v. Express Scripts, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pearson's Pharmacy, Inc. v. Express Scripts, Inc., 378 F. App'x 934 (11th Cir. 2010).

Opinion

PER CURIAM:

Pearson’s Pharmacy and Cam Enterprises appeal the summary judgment in favor of Express Scripts. The district court ruled that Express Scripts did not breach its contracts with Pearson’s and *935 Cam by failing to update daily drug cost information because Express Scripts retained sole discretion to amend the manual that determined the frequency of the price updates and did not abuse that discretion or act in bad faith. We affirm.

I. BACKGROUND

Pearson’s and Cam own and operate retail pharmacies in Dadeville and Birmingham, Alabama. Express Scripts is a pharmacy benefit manager that contracts with third-party payors and health plan administrators to facilitate the delivery of medications to members of prescription drug programs. Express Scripts is headquartered in Missouri.

In 1995, Express Scripts executed a Pharmacy Agreement with Pearson’s, and Express Scripts and Cam executed a similar agreement in 1999. The agreements provided that Pearson’s and Cam would fill prescriptions for members of prescription drug programs and receive payment for those prescriptions based on reimbursement rates defined by Express Scripts. Express Scripts was prohibited from amending the agreement, other than to “comply with any changes required or suggested by ... regulatory authorities,” unless it gave written notice to and obtained the consent of Pearson’s and Cam.

Schedules incorporated in the agreements provided calculations used to reimburse Pearson’s and Cam under different prescription drag programs, including a program for the Department of Defense. The schedules stated that, for a brand name drug, the pharmacies would be paid the “Average Wholesale Price” of the drug minus a stated percentage. The schedules did not define the term “average wholesale price,” identify a source used to determine the average wholesale price, or state the frequency with which Express Scripts would determine or update the average wholesale price.

The agreements stated that the “Provider Manual” was part of the contract. The manual contained the “practices, policies, rules and procedures” governing reimbursement from Express Scripts. Express Scripts agreed, in subsection E of section 2 of the agreements, to “comply with” the manual.

Express Scripts retained the right to amend freely the manual. The Definitions section of Pearson’s agreement stated that the manual “may be revised from time to time,” and the same section in Cam’s agreement stated that the manual “may be revised from time to time ... in [the] sole discretion” of Express Scripts. The Miscellaneous section of both agreements stated that Express Scripts could amend “the Provider Manual and all policies and procedures of [Express Scripts], in its sole discretion, and such amendment shall not require consent of Provider or a ... Pharmacy.” The cover of the manual stated that any “[r]evisions, amendments and program updates will be periodically distributed to the Pharmacy Network.”

Express Scripts periodically replaced the manual, and Pearson’s and Cam received five versions of the manual. The manual stated that Express Scripts based its reimbursement “on the lower of’ the “Average Wholesale Price less the contracted discount,” the baseline price minus the contracted discount, the maximum allowable cost or submitted cost, or the retail price, “[w]hichever is lowest.” The 1997 manual stated that Express Scripts would “update drug information on a weekly basis,” but the manuals issued in 2002, 2004, 2005, and 2006 stated that Express Scripts would “update drug information on a daily basis.”

In February 2006, Pearson’s and Cam filed an amended complaint that Express Scripts had breached its agreements to reimburse for brand name prescription *936 drugs at the average wholesale price as updated on a daily basis. Pearson’s and Cam alleged that the price of brand name drugs typically increased and the failure of Express Scripts to make daily updates had “increased [its] profits” and had caused the pharmacies to “lose money.” Pearson’s and Cam complained that Express Scripts had breached its contracts, made misrepresentations and suppressed information, and been unjustly enriched. Pearson’s and Cam also requested injunctive relief that Express Scripts “be required to properly reimburse” the pharmacies “using the ‘real time’ Average Wholesale Price.”

Pre-trial discovery revealed that Express Scripts processed claims for payment to pharmacies using three computer systems: ANCHOR, mini-ANCHOR, and STRATUS. Express Scripts used the ANCHOR system to process commercial claims, the STRATUS system to process worker’s compensation claims, and the mini-ANCHOR system to process claims from the Department of Defense. During discovery, representatives of Express Scripts testified that the company received daily, weekly, and monthly updates for the average wholesale price, and the cost updates were downloaded daily to the ANCHOR and STRATUS systems. According to the representatives, the price updates are available on the systems approximately 30 hours after they are received. The representatives testified that Express Scripts receives First DataBank price update files between 7 p.m. and 2 a.m., the files are downloaded by 7 a.m., any errors are resolved with First DataBank, and the files are loaded onto the Express Script systems starting at 8 p.m. The representatives explained that the majority of price updates are not immediate, but are available to use for reimbursement on the effective date. Express Scripts admitted that the mini-ANCHOR system was updated weekly instead of daily to accommodate the vendor for the Department of Defense. A representative of Express Scripts testified the company did not “have control over” the updating requirement.

Express Scripts moved to dismiss the complaints of misrepresentation and unjust enrichment, which the district court granted. The parties then moved to stay the action on the ground that “[a]n identical national class action asserting th[os]e same claims” against Express Scripts was pending in another federal court. See Inola Drug, Inc. v. Express Scripts, Inc., No. 06-CV-117, 2009 WL 801838 (N.D.Okla. Mar. 25, 2009). The district court stayed the action until the court in India Drug granted summary judgment in favor of Express Scripts.

Both parties moved for a judgment in their favor. Pearson’s and Cam moved for partial summary judgment on the ground that Express Scripts had admitted it had made weekly instead of daily price updates to the mini-ANCHOR system. Express Scripts moved for summary judgment.

The district court granted summary judgment in favor of Express Scripts. The district court ruled that Express Scripts was not liable to Pearson’s or Cam for breach of contract because Express Scripts had retained sole discretion to revise its manual and had not abused its discretion or acted in bad faith. The district court rejected the arguments of Pearson’s and Cam that amendments to the manual had to be “formal,” “written,” and “distribute[d]” to the pharmacies in an updated manual and there was “no factual support for the contention that [Express Scripts] actually made such an amendment.” The district court ruled that Express Scripts did not have to distribute amended manuals within “any mandatory time intervals or periods” or, “as astutely recognized in Inola Drug,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Missouri Consolidated Health Care Plan v. Community Health Plan
81 S.W.3d 34 (Missouri Court of Appeals, 2002)
Peet v. Randolph
33 S.W.3d 614 (Missouri Court of Appeals, 2000)
Schell v. LifeMark Hospitals of Missouri
92 S.W.3d 222 (Missouri Court of Appeals, 2002)
City of St. Joseph v. Lake Contrary Sewer District
251 S.W.3d 362 (Missouri Court of Appeals, 2008)
Gateway Exteriors, Inc. v. Suntide Homes, Inc.
882 S.W.2d 275 (Missouri Court of Appeals, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
378 F. App'x 934, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pearsons-pharmacy-inc-v-express-scripts-inc-ca11-2010.